Astragaloside IV extracted from Astragalus membranaceus can inhibit IDO expression in IDO-overexpressed lung cancer cells, upregulate co-cultured CD8+CD28+ cells, and downregulate Treg cells (273). This evidence concerns the gene IDO1 and lung cancer.